FOXO3 mutation predicting gefitinib-induced hepatotoxicity in NSCLC patients through regulation of autophagy-Reference-Cited by-同舟云学术

FOXO3 mutation predicting gefitinib-induced hepatotoxicity in NSCLC patients through regulation of autophagy

Published:2022-09 Issue:9 Volume:12 Page:3639-3649
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Guan Shaoxing,Chen Xi,Chen Youhao,Wan Guohui,Su Qibiao,Liang Heng,Yang Yunpeng,Fang Wenfeng,Huang Yan,Zhao Hongyun,Zhuang Wei,Liu Shu,Wang Fei,Feng Wei,Zhang Xiaoxu^ORCID,Huang Min,Wang Xueding,Zhang Li

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference48 articles.

1. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010

2. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol,2010

3. Successful treatment with erlotinib after gefitinib-related severe hepatotoxicity;Takeda;J Clin Oncol,2010

4. Side effects related to cancer treatment: CASE 1. Hepatitis following treatment with gefitinib;Ho;J Clin Oncol,2005

5. Recent advances in understanding the hepatotoxicity associated with protein kinase inhibitors;Shi;Expert Opin Drug Metab Toxicol,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatotoxicity of epidermal growth factor receptor - tyrosine kinase inhibitors (EGFR-TKIs);Drug Metabolism Reviews;2024-08-09

2. Anti‐Müllerian hormone induces autophagy to preserve the primordial follicle pool in mice;The FASEB Journal;2024-02-27

3. Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication;Pharmaceuticals;2023-11-07

4. Metabolic activation of tyrosine kinase inhibitors: recent advance and further clinical practice;Drug Metabolism Reviews;2022-12-01

5. Formulation Development, Optimization by Box-Behnken Design, and In Vitro Characterization of Gefitinib Phospholipid Complex Based Nanoemulsion Drug Delivery System;Journal of Pharmaceutical Innovation;2022-11-14